Streetbeat News

Regulatory

LYFT

UBER

A U.S. appeals court has rejected Uber and Postmates' challenge to California's AB5 law, which could force them to classify drivers as employees. Uber maintains that drivers remain contractors under Proposition 22, which is under separate review. The ruling is part of a broader national debate on gig economy regulations.

Portfolio Pulse from Benzinga Neuro

June 11, 2024 | 5:56 am

MSFT

Bill Gates' TerraPower has started construction on an advanced nuclear power plant in Wyoming, aiming to provide safe, abundant, zero-carbon energy. The project, located next to PacifiCorp’s Naughton Power Plant, will use sodium for cooling and is expected to be operational by 2030. This marks a significant step in reducing fossil fuel reliance and combating climate change.

Portfolio Pulse from Benzinga Neuro

June 11, 2024 | 5:29 am

BTCUSD

Edward Snowden criticized Senator Elizabeth Warren's anti-Bitcoin stance by comparing it to the Chinese Communist Party's perspective. Snowden's remarks were made in a cheeky X post.

Portfolio Pulse from Aniket Verma

June 11, 2024 | 2:58 am

KPRX

Trading for Kiora Pharmaceuticals, Inc. (KPRX) was halted at 7:50:00 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:50 pm

GNFT

Trading for GNFT was halted and has now resumed as of 5:50:00 PM ET. Investors should be aware of the potential volatility following the resumption of trading.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:50 pm

GNFT

IPSEY

GENFIT's Iqirvo, the first-ever drug developed in-house by the company, has received FDA approval. GENFIT is set to receive a €48.7 million milestone payment from Ipsen upon the first commercial sale in the U.S., along with tiered double-digit royalties up to 20%.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:26 pm

ADM

ADM Animal Nutrition has expanded its recalls announced in March and April to include additional products due to elevated levels of magnesium, sodium, calcium, chloride, and/or phosphorus. No illnesses have been reported to date.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:05 pm

BITF

Bitfarms announced that it has been notified by the Toronto Stock Exchange (TSX) regarding the deferral of consideration of its shareholder rights plan.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:03 pm

GNFT

IPSEY

Ipsen announced that Iqirvo has secured FDA accelerated approval as the first-in-class PPAR treatment for primary biliary cholangitis. Iqirvo, an oral, once-daily PPAR agonist, was in-licensed from GENFIT in 2021.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 8:59 pm

GNFT

Trading for GNFT was halted at 4:42:03 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 8:42 pm